 1 Agents affecting nervous system and sensory organs
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
 2111 Nikethamides
|
2112 Camphors
|
2113 Digitalis
|
2114 Strophanthus
|
2115 Caffeines
|
2116 Glycosides
|
2117 Oriental bezoar
|
2118 Alkaloids
|
2119 Others
|
D01573 Etilefrine hydrochloride (JP18)
D01390 Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN)
D02150 l-Isoprenaline hydrochloride (JP18)
D00633 Dopamine hydrochloride (JP18/USP)
D00632 Dobutamine hydrochloride (JP18/USP)
D00417 Milrinone (JAN/USP/INN)
D01238 Bucladesine sodium (JAN)
D01065 Ubidecarenone (JP18/INN)
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
D01133 Pimobendan (JAN/USAN/INN)
D01697 Colforsin daropate hydrochloride (JAN)
D01903 Docarpamine (JAN/INN)
D02042 Olprinone hydrochloride hydrate (JAN)
D02614 Denopamine (JAN/INN)
|
212 Antiarrhythmic agents
|
213 Diuretics
|
214 Antihypertensives
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
217 Vasodilators
|
218 Hyperlipidemia agents
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan